Drug profile · INN
lonafarnib
ZOKINVY
lonafarnib (ZOKINVY) is a protein farnesyltransferase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — lonafarnib
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 0
- Data quality
- 0.84
Quick answer
lonafarnib (ZOKINVY) is a protein farnesyltransferase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Protein farnesyltransferase inhibitor
Primary target: Protein farnesyltransferase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related patents
Frequently asked questions
What is lonafarnib?
lonafarnib (ZOKINVY) is a protein farnesyltransferase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lonafarnib?
ZOKINVY is a marketed brand name for lonafarnib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lonafarnib?
lonafarnib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.